Cargando…
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus
Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.
Autores principales: | Arima, Hiroshi, Cheetham, Timothy, Christ-Crain, Mirjam, Cooper, Deborah, Drummond, Juliana, Gurnell, Mark, Levy, Miles, McCormack, Ann, Newell-Price, John, Verbalis, Joseph G, Wass, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759163/ https://www.ncbi.nlm.nih.gov/pubmed/36355385 http://dx.doi.org/10.1210/clinem/dgac547 |
Ejemplares similares
-
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
por: Arima, Hiroshi, et al.
Publicado: (2022) -
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
por: Arima, Hiroshi, et al.
Publicado: (2022) -
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus
por: Arima, Hiroshi, et al.
Publicado: (2023) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of
diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2021)